Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 10, 2014Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease
A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System for the treatment of...
-
Jun 10, 2014Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease
A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System for the treatment of...
-
Jun 4, 2014
Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus™ Valve System. The RESPOND Registry will collect data on...
-
May 29, 2014I dati dello studio EVOLVE presentati nell'ambito dell’EuroPCR 2014 hanno dimostrato un eccellente profilo di sicurezza
Boston Scientific Corporation (NYSE: BSX) ha riportato dati positivi di follow-up a tre anni dello studio clinico EVOLVE, che confronta la sicurezza e la performance di SYNERGY™, stent...
-
May 27, 2014Solo l'1,1% dei pazienti ha manifestato rigurgito aortico paravalvolare moderato; non si sono verificati casi severi
Con un'ulteriore conferma della sua tecnologia avanzata per l'impianto transcatetere della valvola aortica (TAVI), il dispositivo Lotus?, di Boston Scientific Corporation (NYSE: BSX), continua a...